PHOXILLUM B22K 4 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phoxillum B22k 4, and when can generic versions of Phoxillum B22k 4 launch?
Phoxillum B22k 4 is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.
The generic ingredient in PHOXILLUM B22K 4 is calcium chloride; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate. There are two hundred and eighty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHOXILLUM B22K 4?
- What are the global sales for PHOXILLUM B22K 4?
- What is Average Wholesale Price for PHOXILLUM B22K 4?
Summary for PHOXILLUM B22K 4
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | PHOXILLUM B22K 4 at DailyMed |
US Patents and Regulatory Information for PHOXILLUM B22K 4
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER | calcium chloride; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate | INJECTABLE;INJECTION | 207026-002 | Jan 13, 2015 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
